These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23842688)

  • 41. [Telmisartan, ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial].
    Liakishev AA
    Kardiologiia; 2008; 48(5):72. PubMed ID: 18537808
    [No Abstract]   [Full Text] [Related]  

  • 42. Cilostazol: improving walking distance in patients with intermittent claudication.
    Collinson DJ; Donnelly R
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):503-9. PubMed ID: 15225110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Roles of ACE Inhibitors in Lower Extremity Peripheral Artery Disease.
    Barrons RW; Woods JA
    Am J Ther; 2016; 23(1):e7-15. PubMed ID: 24786850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical impact of exercise in patients with peripheral arterial disease.
    Novakovic M; Jug B; Lenasi H
    Vascular; 2017 Aug; 25(4):412-422. PubMed ID: 28256934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ramipril.
    Smith WH; Ball SG
    Int J Clin Pract; 2000 May; 54(4):255-60. PubMed ID: 10912316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The reduction of cardiovascular risk with ramipril].
    Vanuzzo D
    Ital Heart J Suppl; 2000 May; 1(5):713-4. PubMed ID: 10834142
    [No Abstract]   [Full Text] [Related]  

  • 47. Ramipril and risk of diabetes.
    Potyk DK
    JAMA; 2002 Jan; 287(2):186; author reply 186-7. PubMed ID: 11779250
    [No Abstract]   [Full Text] [Related]  

  • 48. Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.
    Lindgren H; Qvarfordt P; Åkesson M; Bergman S; Gottsäter A;
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):686-694. PubMed ID: 28372983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ramipril: clinical and economic benefits.
    Laking G; Lord J
    Intern Med J; 2004 Jul; 34(7):442. PubMed ID: 15271184
    [No Abstract]   [Full Text] [Related]  

  • 50. [Efficiency of ramipril treatment in patients with chronic obstructive bronchitis complicated by chronic cor pulmonale].
    Butorov IV; Vatulin VN; Bodrug NI; Fuduleĭ RF; Matkovskiĭ SK; Butorova VG
    Probl Tuberk; 1999; (6):42-4. PubMed ID: 10715959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease.
    Hiatt WR; Hirsch AT; Creager MA; Rajagopalan S; Mohler ER; Ballantyne CM; Regensteiner JG; Treat-Jacobson D; Dale RA; Rooke T
    Vasc Med; 2010 Jun; 15(3):171-9. PubMed ID: 20212073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telmisartan, ramipril, or both in patients at high risk of vascular events.
    Büchner N; Banas B; Krämer BK
    N Engl J Med; 2008 Jul; 359(4):426. PubMed ID: 18650521
    [No Abstract]   [Full Text] [Related]  

  • 55. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ramipril on cardiovascular events in high-risk patients.
    Sharma AM; Pischon T; Engeli S
    N Engl J Med; 2000 Jul; 343(1):65; author reply 66. PubMed ID: 10896545
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE
    Hypertension; 2009 Jul; 54(1):40-6. PubMed ID: 19433778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cilostazol is effective and safe option for the treatment of intermittent claudication. Results of the NOCLAUD study].
    Farkas K; Járai Z; Kolossváry E
    Orv Hetil; 2017 Jan; 158(4):123-128. PubMed ID: 28116935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ramipril on the incidence of diabetes.
    Potter BJ; LeLorier J
    N Engl J Med; 2007 Feb; 356(5):522-3; author reply 523-4. PubMed ID: 17274113
    [No Abstract]   [Full Text] [Related]  

  • 60. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.